2014-06 | Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning | 엄지은 |
2011-05 | Analysis of Prognostic Factors of Pediatric-Type Sarcomas in Adult Patients | 엄지은 |
2016-02 | Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study | 엄지은 |
2017-12 | Antitumoral effect of arsenic compound, sodium metaarsenite (KML001), on multiple myeloma cells | 엄지은 |
2015-07 | Incidence and Risk Factors for Vzv Infection after Allogeneic Hematopoietic Cell Transplantation in 1,045 Patients: Younger Age Less Than or Equal to 45, Occurrence of Cgvhd By NIH Consensus Criteria, and No T-Cell Depletion | 엄지은 |
2012-12 | Multiple Single-Nucleotide Polymorphism-Based Risk Model for Clinical Outcomes After Allogeneic Stem-Cell Transplantation, Especially for Acute Graft-Versus-Host Disease | 엄지은 |
2014-07 | Outcomes of Hematopoietic Cell Transplantation in Adult Patients with Acquired Aplastic Anemia Using Intermediate-Dose Alemtuzumab-Based Conditioning | 엄지은 |
2016-03 | The potential of deferasirox as a novel therapeutic modality in gastric cancer | 엄지은 |
2011-04 | Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes | 엄지은 |
2011-06 | Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models | 엄지은 |
2015-07 | Prolonged Duration of Systemic Immunosuppression after Allogeneic Hematopoietic Cell Transplantation Associates with the Use of Peripheral Blood Stem Cells, Severe Grade of Chronic Gvhd, Progressive Type Onset of Chronic Gvhd, Grade 2-4 Acute Gvhd and Older Age, but Not with T-Cell Depletion or Conditioning Regimen | 엄지은 |
2012-01 | Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy | 엄지은 |
2012-01 | Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy | 엄지은 |
2020-07 | Recent advances in chronic lymphocytic leukemia therapy | 엄지은 |
2014-03 | Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models | 엄지은 |
2018-03 | Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment | 엄지은 |
2012-04 | Treatment of newly diagnosed advanced stage Hodgkin lymphoma | 엄지은 |
2019-03 | Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma | 엄지은 |
2018-03 | Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis | 엄지은 |